AO 1535 manufacturers
- AO-1535
-
- $1980.00
-
2026-04-21
- CAS:87178-48-1
- Purity:
- Supply Ability: 10g
|
| | AO 1535 Basic information |
| Product Name: | AO 1535 | | Synonyms: | AO 1535;3-Pyridinecarboxamide, N-[1-[(β-D-galactopyranosyloxy)methyl]-2-hydroxy-3-heptadecenyl]-, (1S,2R,3E)- (9CI) | | CAS: | 87178-48-1 | | MF: | C30H50N2O8 | | MW: | 566.73 | | EINECS: | | | Product Categories: | | | Mol File: | 87178-48-1.mol |  |
| | AO 1535 Chemical Properties |
| Boiling point | 813.0±65.0 °C(Predicted) | | density | 1.20±0.1 g/cm3(Predicted) | | pka | 12.42±0.46(Predicted) |
| | AO 1535 Usage And Synthesis |
| Description | AO-1535 is a semisynthetic monoglycosylceramide derived from O-glycosilated sphingosine. It has been shown to inhibit superoxide production by macrophages suggesting a potential clinical application of AO 1535 in the treatment of inflammatory dermatoses. | | Uses | AO-1535 is a semisynthetic monoglycosylceramide that inhibits the production of reactive oxygen intermediates in human monocytes and macrophages stimulated by phorbol ester and chemotactic tetrapeptide. AO-1535 can be used for the research of inflammatory dermatoses[1]. | | References | [1] Spampinato G, et al. AO 1535 inhibits O2- production by human macrophages. Immunopharmacology. 1992 Jul-Aug;24(1):25-30. DOI:10.1016/0162-3109(92)90066-l |
| | AO 1535 Preparation Products And Raw materials |
|